247 related articles for article (PubMed ID: 9034592)
1. Antisense approaches to the gene therapy of cancer--'Recnac'.
Gibson I
Cancer Metastasis Rev; 1996 Sep; 15(3):287-99. PubMed ID: 9034592
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic antisense and ribozymes.
Rossi JJ
Br Med Bull; 1995 Jan; 51(1):217-25. PubMed ID: 7767645
[TBL] [Abstract][Full Text] [Related]
3. Anti-genes: siRNA, ribozymes and antisense.
Scanlon KJ
Curr Pharm Biotechnol; 2004 Oct; 5(5):415-20. PubMed ID: 15544489
[TBL] [Abstract][Full Text] [Related]
4. Specific regulation of gene expression by antisense nucleic acids: a summary of methodologies and associated problems.
Kawasaki H; Machida M; Komatsu M; Li HO; Murata T; Tsutsui H; Fujita A; Matsumura M; Kobayashi Y; Taira K; Yokoyama KK
Artif Organs; 1996 Aug; 20(8):836-48. PubMed ID: 8853793
[TBL] [Abstract][Full Text] [Related]
5. Antisense oligonucleotides as therapeutic agents.
Alama A; Barbieri F; Cagnoli M; Schettini G
Pharmacol Res; 1997 Sep; 36(3):171-8. PubMed ID: 9367660
[TBL] [Abstract][Full Text] [Related]
6. A good antisense molecule is hard to find.
Branch AD
Trends Biochem Sci; 1998 Feb; 23(2):45-50. PubMed ID: 9538686
[TBL] [Abstract][Full Text] [Related]
7. Targeting Long Noncoding RNA with Antisense Oligonucleotide Technology as Cancer Therapeutics.
Zhou T; Kim Y; MacLeod AR
Methods Mol Biol; 2016; 1402():199-213. PubMed ID: 26721493
[TBL] [Abstract][Full Text] [Related]
8. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension.
Phillips MI
Hypertension; 1997 Jan; 29(1 Pt 2):177-87. PubMed ID: 9039099
[TBL] [Abstract][Full Text] [Related]
9. Neutrally charged phosphorodiamidate morpholino antisense oligomers: uptake, efficacy and pharmacokinetics.
Arora V; Devi GR; Iversen PL
Curr Pharm Biotechnol; 2004 Oct; 5(5):431-9. PubMed ID: 15544491
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic nucleic acids: current clinical status.
Sridharan K; Gogtay NJ
Br J Clin Pharmacol; 2016 Sep; 82(3):659-72. PubMed ID: 27111518
[TBL] [Abstract][Full Text] [Related]
11. Making sense of antisense.
Murakami A
Trends Mol Med; 2001 Oct; 7(10):430-1. PubMed ID: 11597507
[No Abstract] [Full Text] [Related]
12. Antisense oligonucleotides in cancer.
Castanotto D; Stein CA
Curr Opin Oncol; 2014 Nov; 26(6):584-9. PubMed ID: 25188471
[TBL] [Abstract][Full Text] [Related]
13. Design and applications of modified oligonucleotides.
Gallo M; Montserrat JM; Iribarren AM
Braz J Med Biol Res; 2003 Feb; 36(2):143-51. PubMed ID: 12563516
[TBL] [Abstract][Full Text] [Related]
14. Processing of chimeric antisense oligonucleotides by human vascular smooth muscle cells and human atherosclerotic plaque. Implications for antisense therapy of restenosis after angioplasty.
Pickering JG; Isner JM; Ford CM; Weir L; Lazarovits A; Rocnik EF; Chow LH
Circulation; 1996 Feb; 93(4):772-80. PubMed ID: 8641007
[TBL] [Abstract][Full Text] [Related]
15. Antisense oligonucleotide therapy in the management of bladder cancer.
So A; Rocchi P; Gleave M
Curr Opin Urol; 2005 Sep; 15(5):320-7. PubMed ID: 16093856
[TBL] [Abstract][Full Text] [Related]
16. Antisense approaches to cancer gene therapy.
Mercola D; Cohen JS
Cancer Gene Ther; 1995 Mar; 2(1):47-59. PubMed ID: 7621254
[TBL] [Abstract][Full Text] [Related]
17. RNA as a target for developing antivirals.
McKnight KL; Heinz BA
Antivir Chem Chemother; 2003 Mar; 14(2):61-73. PubMed ID: 12856917
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic applications of antisense oligonucleotides in asthma and allergy.
Isidoro-García M; Dávila I
Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):171-5. PubMed ID: 19075979
[TBL] [Abstract][Full Text] [Related]
19. [The application of antisense technology in ophthalmology].
Guo Y; Ge J
Yan Ke Xue Bao; 1998 Jun; 14(2):108-15. PubMed ID: 12580046
[TBL] [Abstract][Full Text] [Related]
20. [Antisense nucleic acids and gene therapy].
Saison-Behmoaras E
Bull Cancer; 1995 Mar; 82(3):224-5. PubMed ID: 7655155
[No Abstract] [Full Text] [Related]
[Next] [New Search]
